Gerresheimer AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRRMF research report →
About the company
Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors.
- CEO
- Uwe Ferdinand Röehrhoff
- IPO
- 2009
- Employees
- 13,632
- HQ
- Düsseldorf, DE
Price Chart
- Market Cap
- $1.06B
- P/E
- -70.35
- P/S
- 0.58
- P/B
- 0.90
- EV/EBITDA
- 8.62
- Div Yield
- 0.14%
- Gross Margin
- 25.19%
- Op Margin
- 6.79%
- Net Margin
- -0.81%
- ROE
- -1.01%
- ROIC
- 3.64%
- Revenue
- $2.04B · 2.28%
- Net Income
- $109.72M · -5.52%
- EPS
- $3.18 · -8.62%
- Op Income
- $197.47M
- FCF YoY
- -284.31%
- 52W High
- $56.75
- 52W Low
- $19.16
- 50D MA
- $29.77
- 200D MA
- $39.66
- Beta
- 0.47
- Avg Volume
- 22
Get TickerSpark's AI analysis on GRRMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GRRMF coverage
Recent articles, reports, and earnings notes.
No research on GRRMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRRMF report →Similar companies
Peers in the same neighborhood.